Nghiem, P., Bhatia, S., Lipson, E. J., Sharfman, W. H., Kudchadkar, R. R., Friedlander, P. A., … Topalian, S. L. (2018). Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy. In Journal of Clinical Oncology (Vol. 36, pp. 9506–9506). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.9506

Nghiem, Paul, Shailender Bhatia, Evan J. Lipson, William Howard Sharfman, Ragini Reiney Kudchadkar, Philip Adam Friedlander, Andrew Scott Brohl, et al. “Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy.” In Journal of Clinical Oncology, 36:9506–9506. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.9506.

Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Friedlander PA, et al. Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 9506–9506.

Nghiem, Paul, et al. “Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 9506–9506. Crossref, doi:10.1200/jco.2018.36.15_suppl.9506.

Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Friedlander PA, Brohl AS, Daud A, Kluger HM, Reddy SA, Burgess MA, Hanks BA, Olencki T, Boulmay BC, Lundgren LM, Ramchurren N, Homet Moreno B, Sharon E, Cheever MA, Topalian SL. Durable tumor regression and overall survival (OS) in patients with advanced Merkel cell carcinoma (aMCC) receiving pembrolizumab as first-line therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 9506–9506.